The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Cariprazine has a unique pharmacological feature of being a partial agonist with high affinity for D3 receptors, making it a potent and efficacious second-generation antipsychotic. The authors discuss its mechanism of action, administration and pharmacokinetics, and indications, as well as clinical studies and special populations regarding the use of this promising medication.